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nnovation, Journal
eviewers, and Journal Editors
he Game Is Worth the Candle*
ichard L. Popp, MD, MACC†
tanford, California
ew ideas are the basis for practical therapies that ulti-
ately benefit patients. At the time of their initial enunci-
tion, really creative new ideas regarding biology, medical
rocedures, or medical devices often seem strange, or even
ay be considered “crazy” and unlikely to stand the test of
ime. So how are we exposed to these innovative ideas? The
ast majority of academic investigators would like to publish
heir attempts to test such new approaches in the “best”
ournals that reach the appropriately interested audience.
See page 1354
here are many anecdotes about the difficulty encountered
y innovators who tried to publish early work on truly
evolutionary methods such as echocardiography and angio-
lasty. Investigators recognize that this Journal has the
argest readership in, and influence on, the field of cardio-
ascular disease, and they would like to have their work
ublished here. However, the number of articles submitted
or review has skyrocketed in the past few years, and now
20% of the manuscripts submitted to this Journal will be
ccepted for publication. It is the editors’ job to decide
hich manuscripts to publish, realizing that they will
isappoint the majority of their colleagues. The rejected
deas and findings may or may not be published elsewhere.
ow should a set of editors position their policies to benefit
heir readers and their field by sifting out the “wheat from
he chaff” while trying to spot the truly seminal discoveries
nd innovative methods? This is a difficult and serious
ame.
A manuscript submitted for review is the result of a long
equence of events. When a significant scientific problem or
edical need is recognized, it fosters thinking by inventive
hysician-scientists and others to find a solution to that
eed. Innovations, as contrasted with evolutionary advances,
ften rely on a person or team assimilating isolated or
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the †Stanford University School of Medicine, Stanford, California. Dr. Popp
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orp., Tissue Link Medical Inc., and Zonare Inc. He is a Director of the Steeringt
ommittee for Percardia Inc. and Sensant Corp. He is also a stock option holder for
cumen Medical, Cardiac MD, and Neoguide Systems.pparently unrelated past observations for application to a
ew problem. This is an arcane process, and these days the
eam often consists of physician-scientists, engineers, phys-
cists, chemists, and technicians. They work to design
xperimental models of the problem for investigation. They
xpend significant resources to test their hypothesis. They
abor to write a clear and objective manuscript and they are
orced, by convention, to acknowledge the multiple limita-
ions of their approach and conclusions. This enormous
ffort is respected by the journal editors and reviewers
hrough their rigorous process for handling and judging
anuscripts. Both the creation of the manuscript and the
eview of the work are difficult and careful processes.
The process of manuscript review for medical journals is
ritically dependent on the background knowledge of the
eople involved with the assessment of the manuscript.
eviewers have a frame of reference from their training,
ducation, and experience within which they interpret all
ew data. The experts who provide peer review and assist
ditors often know much regarding the background infor-
ation on which a manuscript is based, but they now are
resented with data in a new context. Really new concepts
re rare and often are said to be “out of the box.” This phrase
ecognizes that we usually think inside a box that is
elineated by our experience. In this issue of the Journal, as
s customary, there are articles describing very early work. I
ssume the editors had to think long and hard to establish
riority for these articles compared with others received.
One of these articles in this issue of the Journal uses a
arotid intra-arterial electrode catheter for sympathetic
erve stimulation (SNS) to the heart with the goal of
tudying the effects of this intervention on cardiac hemo-
ynamics and electrophysiology (1). This appears to follow
n prior work from this group exploring the effects of
ransvenous catheter stimulation of cardiac parasympathetic
erves in humans (2). The results of the current work in
wine are of such magnitude that one may find them
urprising. The systolic arterial pressure increased acutely in
graded fashion up to 100% from baseline during SNS
hile peripheral vascular resistance was unchanged. How-
ver, SNS provoked atrial fibrillation in many animals, and
NS in the left carotid caused accelerated idioventricular
hythms as well. Could this eventually be a therapy for acute
nd severe left ventricular failure and cardiogenic shock? I
ssume that the reviewers of this article could properly judge
he construction of the experiment and the analysis of the
esults, but they cannot know all one would wish to know to
ully evaluate and understand the basis for, or the clinical
mplications of, these findings. I imagine the editors had
ifferences of opinion about the importance, and thus the
riority, that they should give such an article. I further
magine that some around the table thought this was an
mpractical idea that might never be useful clinically
hereas others thought this development was so importanthat it must have higher priority. We know how the
d
f
n
s
t
w
c
p
t
e
i
f
p
j
i
t
f
h
i
c
i
p
y
W
t
m
p
R
P
D
s
r
R
1
2
1361JACC Vol. 46, No. 7, 2005 Popp
October 4, 2005:1360–1 Editorial Commentiscussion came out in this case because the article is here
or all to see.
Exposure of really new approaches to clinically recog-
ized problems is one of the important functions of journals
uch as this one. Editors have no crystal ball to allow them
o predict which among the manuscripts with “crazy” ideas
ill turn out to be the basis for a great advance in patient
are. Authors naturally gripe about this somewhat imperfect
rocess when their own work is not accepted. However, I
hink we need to step back occasionally and commend the
ditors and reviewers for sorting through these difficult
ssues, making the positive decision to take chances on
ar-out ideas and bringing these challenging manuscripts to
ublication. I accept that those involved in the process of
udgment do not have easy, reproducible answers to the
ssues of scientific understanding of “out of the box” ideas
esting that they can reproducibly apply in the present and
uture. Nevertheless, many would agree with me that the
uge effort expended in evaluation of such innovative work
s justified. The cardiovascular community, including the
ommercial partners of that community, can be proud of themprovements in the quality and duration of life for our
atients that have come from their innovations over the 40
ears of my medical career. “The game is worth the candle.”
e should continue to read this Journal with the expecta-
ion of finding the newest ideas and the most innovative
ethods that point us to future advances in cardiovascular
atient care.
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